Back

Validation of two simple scores to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction

31 August 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Cardiac amyloidosis: how to stage and score Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Mireia Llevadot Sesmilo

Germans Trias and Pujol Hospital, Badalona (Spain)

7 More presentations in this session

Presentation thumbnail
DPD quantification correlates with ECV and disease severity in patients with ATTR-CM
Doctor R. Rettl (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Prognostic significance of right ventricular dysfunction in patients with TTR amyloidosis
Doctor S. Istratoaie (Cluj Napoca, RO) Professor E. Donal (Rennes, FR)
Abstract Slides Video
Presentation thumbnail
Characterizing the progression of subclinical cardiac amyloidosis through artificial intelligence applied to electrocardiographic images and echocardiograms
Doctor E. Oikonomou (New Haven, US)
Abstract Slides Video
Presentation thumbnail
Prognostic staging system correctly identifies high risk groups in cardiac transthyretin amyloidosis treated with tafamidis
Mr M. Mueller (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging
Doctor J. Li (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac amyloidosis: how to stage and score

The Event

Event poster

ESC Congress 2024

31 August 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Validation of two clinical scores for transthyretin amyloid cardiomyopathy in a mediterranean cohort of patients at risk
thumbnail
Congress Presentation
Development of TTRACK study diagnostic scores to identify elevated risk of transthyretin amyloid cardiomyopathy in older patients with unexplained hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Simple and specific prediction of the final diagnosis in patients with suspected amyloid cardiomyopathy and indication to tissue biopsy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources